La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.

Identifieur interne : 000648 ( Main/Curation ); précédent : 000647; suivant : 000649

Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.

Auteurs : Yueting Shao [Canada] ; Daniel Figeys ; Zhibin Ning ; Ryan Mailloux ; Hing Man Chan

Source :

RBID : pubmed:26558463

English descriptors

Abstract

Exposure to environmental chemicals has been implicated as a possible risk factor for the development of neurodegenerative diseases. Our previous study showed that methylmercury (MeHg) exposure can disrupt synthesis, uptake and metabolism of dopamine similar to 1-methyl-4-phenylpyridinium (MPP(+)). The objective of this study was to investigate the effects of MeHg exposure on gene and protein profiles in a dopaminergic MN9D cell line. MN9D cells were treated with MeHg (1-5 μM) and MPP(+) (10-40 μM) for 48 hr. Real-time PCR Parkinson's disease (PD) arrays and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) were performed for the analysis. PD PCR array results showed that 19% genes were significantly changed in the 2.5 μM MeHg treated cells, and 39% genes were changed in the 5 μM MeHg treated cells. In comparison, MPP(+) treatment (40 µM) resulted in significant changes in 25% genes. A total of 15 common genes were altered by both MeHg and MPP(+), and dopaminergic signaling transduction was the most affected pathway. Proteomic analysis identified a total of 2496 proteins, of which 188, 233 and 395 proteins were differentially changed by 1 μM and 2.5 μM MeHg, and MPP(+) respectively. A total of 61 common proteins were changed by both MeHg and MPP(+) treatment. The changed proteins were mainly involved in energetic generation-related metabolism pathway (propanoate metabolism, pyruvate metabolism and fatty acid metabolism), oxidative phosphorylation, proteasome, PD and other neurodegenerative disorders. A total of 7 genes/proteins including Ube2l3 (Ubiquitin-conjugating enzyme E2 L3) and Th (Tyrosine 3-monooxygenase) were changed in both genomic and proteomic analysis. These results suggest that MeHg and MPP(+) share many similar signaling pathways leading to the pathogenesis of PD and other neurodegenerative diseases.

DOI: 10.2131/jts.40.817
PubMed: 26558463

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26558463

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.</title>
<author>
<name sortKey="Shao, Yueting" sort="Shao, Yueting" uniqKey="Shao Y" first="Yueting" last="Shao">Yueting Shao</name>
<affiliation wicri:level="1">
<nlm:affiliation>Natural Resources and Environmental Studies Program, University of Northern British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Natural Resources and Environmental Studies Program, University of Northern British Columbia</wicri:regionArea>
<wicri:noRegion>University of Northern British Columbia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Figeys, Daniel" sort="Figeys, Daniel" uniqKey="Figeys D" first="Daniel" last="Figeys">Daniel Figeys</name>
</author>
<author>
<name sortKey="Ning, Zhibin" sort="Ning, Zhibin" uniqKey="Ning Z" first="Zhibin" last="Ning">Zhibin Ning</name>
</author>
<author>
<name sortKey="Mailloux, Ryan" sort="Mailloux, Ryan" uniqKey="Mailloux R" first="Ryan" last="Mailloux">Ryan Mailloux</name>
</author>
<author>
<name sortKey="Chan, Hing Man" sort="Chan, Hing Man" uniqKey="Chan H" first="Hing Man" last="Chan">Hing Man Chan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26558463</idno>
<idno type="pmid">26558463</idno>
<idno type="doi">10.2131/jts.40.817</idno>
<idno type="wicri:Area/PubMed/Corpus">000363</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000363</idno>
<idno type="wicri:Area/PubMed/Curation">000363</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000363</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000363</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000363</idno>
<idno type="wicri:Area/Ncbi/Merge">001D74</idno>
<idno type="wicri:Area/Ncbi/Curation">001D74</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001D74</idno>
<idno type="wicri:Area/Main/Merge">000649</idno>
<idno type="wicri:Area/Main/Curation">000648</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.</title>
<author>
<name sortKey="Shao, Yueting" sort="Shao, Yueting" uniqKey="Shao Y" first="Yueting" last="Shao">Yueting Shao</name>
<affiliation wicri:level="1">
<nlm:affiliation>Natural Resources and Environmental Studies Program, University of Northern British Columbia, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Natural Resources and Environmental Studies Program, University of Northern British Columbia</wicri:regionArea>
<wicri:noRegion>University of Northern British Columbia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Figeys, Daniel" sort="Figeys, Daniel" uniqKey="Figeys D" first="Daniel" last="Figeys">Daniel Figeys</name>
</author>
<author>
<name sortKey="Ning, Zhibin" sort="Ning, Zhibin" uniqKey="Ning Z" first="Zhibin" last="Ning">Zhibin Ning</name>
</author>
<author>
<name sortKey="Mailloux, Ryan" sort="Mailloux, Ryan" uniqKey="Mailloux R" first="Ryan" last="Mailloux">Ryan Mailloux</name>
</author>
<author>
<name sortKey="Chan, Hing Man" sort="Chan, Hing Man" uniqKey="Chan H" first="Hing Man" last="Chan">Hing Man Chan</name>
</author>
</analytic>
<series>
<title level="j">The Journal of toxicological sciences</title>
<idno type="eISSN">1880-3989</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>1-Methyl-4-phenylpyridinium (toxicity)</term>
<term>Cells, Cultured</term>
<term>Dopamine (metabolism)</term>
<term>Dopamine (physiology)</term>
<term>Dopaminergic Neurons (metabolism)</term>
<term>Energy Metabolism (genetics)</term>
<term>Genome (drug effects)</term>
<term>Genomics</term>
<term>Humans</term>
<term>Methylmercury Compounds (toxicity)</term>
<term>Neurotoxicity Syndromes (etiology)</term>
<term>Oxidative Phosphorylation</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Proteasome Endopeptidase Complex</term>
<term>Proteome (drug effects)</term>
<term>Proteomics</term>
<term>Signal Transduction (drug effects)</term>
<term>Tyrosine 3-Monooxygenase (metabolism)</term>
<term>Ubiquitin-Conjugating Enzymes (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en">
<term>Proteome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Dopamine</term>
<term>Tyrosine 3-Monooxygenase</term>
<term>Ubiquitin-Conjugating Enzymes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Dopamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="toxicity" xml:lang="en">
<term>1-Methyl-4-phenylpyridinium</term>
<term>Methylmercury Compounds</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Genome</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Neurotoxicity Syndromes</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Energy Metabolism</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Dopaminergic Neurons</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cells, Cultured</term>
<term>Genomics</term>
<term>Humans</term>
<term>Oxidative Phosphorylation</term>
<term>Proteasome Endopeptidase Complex</term>
<term>Proteomics</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Exposure to environmental chemicals has been implicated as a possible risk factor for the development of neurodegenerative diseases. Our previous study showed that methylmercury (MeHg) exposure can disrupt synthesis, uptake and metabolism of dopamine similar to 1-methyl-4-phenylpyridinium (MPP(+)). The objective of this study was to investigate the effects of MeHg exposure on gene and protein profiles in a dopaminergic MN9D cell line. MN9D cells were treated with MeHg (1-5 μM) and MPP(+) (10-40 μM) for 48 hr. Real-time PCR Parkinson's disease (PD) arrays and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) were performed for the analysis. PD PCR array results showed that 19% genes were significantly changed in the 2.5 μM MeHg treated cells, and 39% genes were changed in the 5 μM MeHg treated cells. In comparison, MPP(+) treatment (40 µM) resulted in significant changes in 25% genes. A total of 15 common genes were altered by both MeHg and MPP(+), and dopaminergic signaling transduction was the most affected pathway. Proteomic analysis identified a total of 2496 proteins, of which 188, 233 and 395 proteins were differentially changed by 1 μM and 2.5 μM MeHg, and MPP(+) respectively. A total of 61 common proteins were changed by both MeHg and MPP(+) treatment. The changed proteins were mainly involved in energetic generation-related metabolism pathway (propanoate metabolism, pyruvate metabolism and fatty acid metabolism), oxidative phosphorylation, proteasome, PD and other neurodegenerative disorders. A total of 7 genes/proteins including Ube2l3 (Ubiquitin-conjugating enzyme E2 L3) and Th (Tyrosine 3-monooxygenase) were changed in both genomic and proteomic analysis. These results suggest that MeHg and MPP(+) share many similar signaling pathways leading to the pathogenesis of PD and other neurodegenerative diseases.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000648 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 000648 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26558463
   |texte=   Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i   -Sk "pubmed:26558463" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022